RECRUITING

Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary aim is to assess the impact of laser setting frequency and wattage during holmium laser enucleation of the prostate. There is currently no gold-standard laser settings for HoLEP procedures. In the investigator's current high-volume practice, the following settings for enucleation are: 2j 50hz. These settings are conventional settings, but there is no literature to prove optimal laser settings. The investigators hypothesizes that utilization of higher laser settings may be associated with a clinically significant (defined as \> 10%) decrease in procedural time without any detrimental postoperative outcomes, and a utilization of lower laser settings may be associated with a clinically significant (defined as \>10%) reduction in postoperative irritative voiding symptoms without any detrimental postoperative outcomes.

Official Title

Laser Outcomes Associated With HoLEP Procedures

Quick Facts

Study Start:2024-03-04
Study Completion:2026-08-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06531473

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 89 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Males 18-89 who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms, that are typically caused by enlarged prostates
  1. * Prostates measurements over 200g
  2. * Patients who lack decisional capacity
  3. * Patients who are non-english speakers

Contacts and Locations

Study Contact

Allaa Fadl-Alla, BS
CONTACT
312-724-3840
allaa.fadlalla@northwestern.edu
Alyssa McDonald, MS
CONTACT
312-724-3840
alyssa.mcdonald@northwestern.edu

Principal Investigator

Amy Krambeck, MD
PRINCIPAL_INVESTIGATOR
Northwestern

Study Locations (Sites)

Northwestern Medicine
Chicago, Illinois, 60611
United States

Collaborators and Investigators

Sponsor: Northwestern University

  • Amy Krambeck, MD, PRINCIPAL_INVESTIGATOR, Northwestern

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-04
Study Completion Date2026-08-30

Study Record Updates

Study Start Date2024-03-04
Study Completion Date2026-08-30

Terms related to this study

Additional Relevant MeSH Terms

  • Urologic Diseases
  • Prostate Obstruction